Novartis Ag (NVSEF) EPS (Basic) (2015 - 2025)
Novartis Ag (NVSEF) posted EPS (Basic) of $0.0 for Q1 2026, up 36.29% sequentially from $0.0 in Q4 2025, and down 6.16% YoY from $0.0 in Q1 2025.
Novartis Ag (NVSEF) EPS (Basic) (2015 - 2025) Analysis & Trends
Novartis Ag (NVSEF) has 14 years of EPS (Basic) data on file, last reported at $0.0 in Q1 2026.
- Quarterly EPS (Basic) fell 6.16% year-over-year to $0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.0 (up 13.63% YoY) and the FY2025 annual result came in at $0.0, up 224.03% from the prior year.
- EPS (Basic) improved to $0.0 in Q1 2026 per NVSEF's latest filing, from $0.0 in the prior quarter.
- The five-year high for EPS (Basic) was $0.0 in Q3 2025, with the low at $0.0 in Q2 2022.
- Average EPS (Basic) over 5 years is $0.0, with a median of $0.0 recorded in 2022.
- Year-over-year, EPS (Basic) tumbled 99.89% in 2022 and soared 154.65% in 2023.
- Novartis Ag's EPS (Basic) stood at $0.0 in 2022, then soared by 154.65% to $0.0 in 2023, then slumped by 64.71% to $0.0 in 2024, then jumped by 136.08% to $0.0 in 2025, then jumped by 36.29% to $0.0 in 2026.
- Business Quant data shows NVSEF's EPS (Basic) at $0.0 in Q1 2026, $0.0 in Q4 2025, and $0.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 8.27 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 2.17 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.39 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 121.99 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -2.35 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 3.37 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.63 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.00 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Novartis Ag | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |
| Dec 31, 2019 | 0.00 |
| Jun 30, 2019 | 0.00 |
| Dec 31, 2018 | 0.00 |
| Jun 30, 2018 | 0.00 |
| Dec 31, 2017 | 0.00 |
| Jun 30, 2017 | 0.00 |
| Dec 31, 2016 | 0.00 |
| Dec 31, 2015 | 0.00 |